CARDIFF ONCOLOGY, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.63 USD | -2.94% |
|
+7.08% | +145.27% |
| 02/05 | Transcript : Cardiff Oncology, Inc., Q1 2024 Earnings Call, May 02, 2024 | |
| 02/05 | Cardiff Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CARDIFF ONCOLOGY, INC. | Other Biotechnology & Medical Research | -2.94% | +7.08% | +145.27% | +105.08% | +17.86% | 16Cr |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- CRDF Stock
- Charts Cardiff Oncology, Inc.
- Comparison Chart
